United States Cannabis Sales Data 2026

California reported $4.6 billion in taxable cannabis sales during 2024, down from $5.3 billion in 2022, according to the California Department of Tax and Fee Administration (CDTFA) [S1]. This is a large, official state series, but it is not United States cannabis sales: no federal retail table combines every state’s medical and adult-use transactions under one definition.

What US cannabis sales data can answer in 2026

The defensible answer is a portfolio of state series. California publishes taxable sales, Illinois publishes monthly adult-use sales, Massachusetts reports Marijuana Enforcement Tracking Reporting Compliance (METRC) gross sales, Colorado publishes marijuana sales, Michigan reports monthly cannabis sales, and Oregon publishes market data [S1-S6].

Each figure can answer a question inside its source definition. Adding them without reconciling medical coverage, wholesale activity, taxes, product scope, reporting lag, and revisions produces a number that looks national but is not nationally standardized.

This article therefore presents comparable-looking figures as separate observations. For the legal and timing context behind one emerging state, see Virginia cannabis market data.

Screenshot-ready official sales comparison

The Illinois, Michigan, and Oregon annual figures are clearly labeled original calculations because the agencies publish monthly observations. They are sums of the cited monthly values, with no seasonality adjustment, inflation adjustment, or forecast extension.

The Massachusetts row is intentionally not ranked against annual totals. Its more than $7 billion value is cumulative, and treating it as one year of sales would be a major period error [S3].

California: large scale, declining nominal sales

CDTFA’s annual table places California taxable cannabis sales at $5.3 billion in 2022, $4.9 billion in 2023, and $4.6 billion in 2024 [S1]. The difference between the first and last values is $0.7 billion, an original subtraction from the official rounded figures.

That decline does not by itself identify a cause. Prices, licensed volume, consumer substitution, reporting compliance, store supply, and illicit-market competition can move independently.

California also changed its cannabis tax structure over time. Analysts should use CDTFA’s definitions and revision notes rather than infer retail revenue from tax receipts by dividing by a current rate across earlier periods [S1].

Illinois: resident and nonresident purchasing

Illinois publishes monthly adult-use sales with separate resident and out-of-state purchaser measures [S2]. That split is useful because it demonstrates that store geography and customer residence are different dimensions.

The $1,722,226,806 annual value in the table is our sum of the agency’s monthly adult-use totals for calendar 2024 [S2]. It excludes medical sales and should not be labeled the complete Illinois cannabis market.

A border-state comparison should retain Illinois’s purchaser-residence fields. Dividing statewide sales only by Illinois population would attribute out-of-state demand to Illinois residents and overstate a resident per-capita measure.

Michigan and Colorado: similar labels, different systems

Michigan’s Cannabis Regulatory Agency releases monthly reports for the medical and adult-use markets [S5]. The $3,274,721,992 row is our calendar-year sum of reported adult-use sales, not an agency forecast and not a US total.

Colorado publishes monthly sales reports and separate tax and fee reports [S4][S7]. Sales are not equivalent to tax revenue, and the state warns that figures can be revised as returns are processed.

The $1,387,091,119 Colorado value is the official calendar 2024 total in the state sales series [S4]. Comparing it with Michigan still requires caution because program maturity, prices, product mix, visitor demand, and reporting definitions differ.

Massachusetts and Oregon: why periods matter

Massachusetts announced that adult-use gross sales had surpassed $7 billion in November 2024 [S3]. This milestone is useful for describing cumulative legal commerce since launch, but it cannot be inserted into an annual ranking.

Oregon’s Liquor and Cannabis Commission publishes monthly retail sales and market reports [S6]. Our $960.5 million annual row is a sum of the calendar 2024 monthly series and is rounded to the nearest $0.1 million, an original calculation.

Annualizing a partial year is a forecast. If an analyst multiplies a year-to-date average by remaining months, the output must be labeled an estimate and should include uncertainty around seasonality and revisions.

Why there is no single official national total

The Census Bureau’s North American Industry Classification System includes cannabis-related activity within broader or evolving retail classifications, but the federal Monthly Retail Trade Survey does not publish a national state-legal cannabis line [S8]. Federal illegality and state-specific licensing further complicate establishment coverage.

State program scope also differs. Some reports include medical and adult-use sales, some publish adult-use only, and some use tax-return values rather than seed-to-sale transactions.

Price presentation differs too. Gross receipts may include discounts before or after adjustment; excise and sales taxes may be excluded or included; wholesale transfers may appear in another table.

A credible national estimate can be commercially useful, but it is still an estimate. Its publisher should identify states included, treatment of medical sales, imputation for missing periods, tax treatment, and revision policy.

Building a reproducible 2026 tracker

Store each observation at its native frequency and preserve the downloaded source. Recommended fields are jurisdiction, program, measure name, period start, period end, dollars, tax treatment, medical coverage, publication date, revision date, and source URL.

Do not overwrite revised values. Keep a vintage field so users can reproduce what a dashboard showed on a past date.

For year-over-year growth, use (current period / prior comparable period - 1) x 100. That equation is a calculation method, not an industry target; both inputs must come from the same agency series and definition.

For per-capita comparisons, use a dated Census population estimate and label the result as an original calculation [S9]. Consider whether tourists and cross-border purchasers make resident population an unsuitable denominator.

Administrative teams can use market research support to maintain approved source files and calculation notes. They should not turn a missing state observation into an invented value.

Operating uses beyond market ranking

Monthly state data can help frame seasonality, but it does not predict one store’s sales. Local competition, hours, assortment, pricing, stock availability, and customer eligibility affect store results.

A multi-state operator can compare its share only when the company numerator and state denominator cover the same products and period. Net revenue after discounts should not be divided by an agency’s gross-sales denominator without explaining the mismatch.

Tax teams should reconcile sales and tax reports rather than assume they move in lockstep. Colorado, for example, maintains distinct sales and tax data pages [S4][S7].

Inventory planners can use state category reports where available, but category names need a crosswalk. “Flower,” “usable marijuana,” and “infused product” are not automatically identical categories across regulators.

Methodology and limitations

We reviewed 12 sources last verified July 23, 2026, prioritizing regulator and revenue-department series. Values in the comparison table use calendar 2024, the latest complete year shared across the selected official series at review time, except the clearly labeled Massachusetts cumulative milestone.

Where an agency supplied monthly rather than annual figures, we summed the calendar months and labeled the output “original calculation.” Rounded source values were not given false extra precision.

We did not create a national sum because the selected states are not the complete country and source definitions are not harmonized. We also excluded market-research forecasts from the factual table.

Limitations

State data can be revised after tax filings, corrections, or seed-to-sale adjustments. Access dates matter, and later extracts may not reproduce the same total.

Sales do not measure consumption, profitability, legal-market capture, or economic impact. A dollar increase can reflect price changes rather than more product sold.

The table is illustrative rather than exhaustive. States with legal medical or adult-use systems are omitted, so the values must never be added and labeled total US sales.

Inflation is not adjusted. Cross-state rankings also ignore differences in population, tourism, launch date, home cultivation, local bans, and tax-inclusive pricing.

Frequently asked questions

How much cannabis did the United States sell in 2026?

No complete official 2026 total exists while the year is in progress, and no federal series harmonizes all state programs. Use dated state observations or a transparently labeled private estimate.

Which state is largest in this official comparison?

California, with $4.6 billion in taxable cannabis sales for calendar 2024 [S1]. That statement applies to the jurisdictions and measures in this table, not every possible market definition.

Can the six values in the table be added?

No. Massachusetts is cumulative, program coverage differs, and the table omits many states. A sum would not represent a defined population or period.

Why use 2024 data in a 2026 report?

A complete, quality-checked calendar year is more comparable than partial 2026 observations. The title describes the review edition; every data period is shown explicitly.

Are cannabis tax receipts the same as sales?

No. Rates, deductions, filing timing, and tax bases intervene between sales and receipts. Use official sales and tax series for their stated purposes [S1][S7].

Sources

1. [S1] California Department of Tax and Fee Administration, Cannabis Tax Revenues, updated May 28, 2025.
2. [S2] Illinois Cannabis Regulation Oversight Office, Sales Figures, official monthly retail-sales dashboard; accessed July 23, 2026.
3. [S3] Massachusetts Cannabis Control Commission, Sales and Product Distribution, official adult-use gross-sales data; accessed July 23, 2026.
4. [S4] Colorado Department of Revenue, Marijuana Sales Reports, 2024 series updated 2025.
5. [S5] Michigan Cannabis Regulatory Agency, Cannabis Regulatory Agency Statistical Report, 2024 monthly reports through December 2024; accessed July 23, 2026.
6. [S6] Oregon Liquor and Cannabis Commission, Marijuana Market Data, 2024 data updated 2025.
7. [S7] Colorado Department of Revenue, Marijuana Tax Reports, updated monthly; accessed July 23, 2026.
8. [S8] US Census Bureau, 2022 NAICS Manual, published 2022; accessed July 23, 2026.
9. [S9] US Census Bureau, State Population Estimates, vintage 2025, released December 2025.
10. [S10] Washington State Liquor and Cannabis Board, Data Portal, updated 2026; accessed July 23, 2026.
11. [S11] Nevada Cannabis Compliance Board, 2025 Biennial Report, published 2025; accessed July 23, 2026.
12. [S12] Maryland Cannabis Administration, Data Dashboard, updated 2026; accessed July 23, 2026.

Conclusion

United States cannabis sales data is most credible when presented as dated, definition-preserving state series rather than one synthetic federal number. If your team needs a maintained source workbook with calculations clearly separated from agency facts, book a free consultation call.